Abstract
Severe acute respiratory syndrome (SARS) is an epidemic that spread worldwide in early 2003. The aetiological agent was originally defined as a novel coronavirus and later designated as the SARS coronavirus (SARSCoV), which appears similar to other coronaviruses in both virion structure and genome organization with a singlestranded, plus-sense RNA. However, the epidemiology and pathogenesis of SARS remain poorly understood and there is currently no effective treatment. To date, considerable research has been done on detection, prevention and treatment of SARS. In this review, we mainly focus on the recent patents and research work on detecting, preventing and treating SARS.
Keywords: SARS, coronavirus, inhibitor, vaccine
Recent Patents on Anti-Infective Drug Discovery
Title: Recent Patents on Treatment of Severe Acute Respiratory Syndrome (SARS)
Volume: 2 Issue: 1
Author(s): Shumei Zhai, Wei Liu and Bing Yan
Affiliation:
Keywords: SARS, coronavirus, inhibitor, vaccine
Abstract: Severe acute respiratory syndrome (SARS) is an epidemic that spread worldwide in early 2003. The aetiological agent was originally defined as a novel coronavirus and later designated as the SARS coronavirus (SARSCoV), which appears similar to other coronaviruses in both virion structure and genome organization with a singlestranded, plus-sense RNA. However, the epidemiology and pathogenesis of SARS remain poorly understood and there is currently no effective treatment. To date, considerable research has been done on detection, prevention and treatment of SARS. In this review, we mainly focus on the recent patents and research work on detecting, preventing and treating SARS.
Export Options
About this article
Cite this article as:
Zhai Shumei, Liu Wei and Yan Bing, Recent Patents on Treatment of Severe Acute Respiratory Syndrome (SARS), Recent Patents on Anti-Infective Drug Discovery 2007; 2 (1) . https://dx.doi.org/10.2174/157489107779561698
DOI https://dx.doi.org/10.2174/157489107779561698 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Topical Calcineurin Inhibitors, Pimecrolimus and Tacrolimus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Oxidized Human Beta2-Glycoprotein I: Its Impact on Innate Immune Cells
Current Molecular Medicine Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Nanotools for the Delivery of Antimicrobial Peptides
Current Drug Targets An overview of ABC and SLC Drug Transporter Gene Regulation
Current Drug Metabolism Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA The Heme Oxygenase System: Its Role in Liver Inflammation
Current Drug Targets - Cardiovascular & Hematological Disorders Corticotropin-Releasing Factor Receptor Antagonists in Affective Disorders and Drug Dependence - An Update
CNS & Neurological Disorders - Drug Targets The Role of Parthenolide in Intracellular Signalling Processes: Review of Current Knowledge
Current Signal Transduction Therapy Synthesis and Anti-Angiogenic Effect of Conjugates Between Serum Albumin and Non-Steroidal Anti-Inflammatory Drugs
Protein & Peptide Letters The Role of IRF1 and IRF2 Transcription Factors in Leukaemogenesis
Current Gene Therapy Oncolytic Virotherapy and Gene Therapy Strategies for Hepatobiliary Cancers
Current Cancer Drug Targets Role of Adipocytokines in Hepatic Fibrosis
Current Pharmaceutical Design Mucin-based Targeted Pancreatic Cancer Therapy
Current Pharmaceutical Design Gut Microbiome and Insomnia: A Mini-Review
New Emirates Medical Journal Determinants of Human Coronary Collaterals
Current Cardiology Reviews Editorial
Inflammation & Allergy - Drug Targets (Discontinued) Tuftsin – Properties and Analogs
Current Medicinal Chemistry Neuropathic Pain: Models and Mechanisms
Current Pharmaceutical Design Monocyte and Macrophage Dysfunction as a Cause of HIV-1 Induced Dysfunction of Innate Immunity
Current Molecular Medicine